• centos7搭建shadowsock
  • Investors
  • English
  • linux安装shadowsock
  • 日本語

Poxel SA

酷通加速器-酷通vqn下载入口-酷通npv官网地址-酷通加速器

For our lead product, Imeglimin, preparations are underway for a New Drug Application in Japan. Imeglimin has successfully completed Phase 2 development in the U.S. and EU. PXL770 and PXL065 are in mid-stage development for NASH. We are also evaluating our AMPK activation and TZD platforms for other chronic and rare metabolic diseases.

View Our Candidates
Targeting Mitochondrial Dysfunction

酷通加速器-酷通vqn下载入口-酷通npv官网地址-酷通加速器

Our candidates are based on disease-modifying mechanisms of action that offer the potential for safer and more effective therapies for type 2 diabetes and NASH.

View Pipeline
Innovative Pipeline of First-In-Class Products

酷通加速器-酷通vqn下载入口-酷通npv官网地址-酷通加速器

Our highly-experienced clinical and regulatory teams possess the know-how and experience to successfully develop products within our pipeline.

Meet Our Team
centos7搭建shadowsock

酷通加速器-酷通vqn下载入口-酷通npv官网地址-酷通加速器

酷通加速器-酷通vqn下载入口-酷通npv官网地址-酷通加速器

Japanese New Drug Application (J-NDA) for Imeglimin is supported by an extensive preclinical and clinical program, including positive results from the Phase 3 TIMES program in over 1,100 patients in Japan Imeglimin…

Read this Press Release: Poxel Announces Submission of Imeglimin Japanese New Drug Application for the Treatment of Type 2 Diabetes by Sumitomo Dainippon Pharma

酷通加速器-酷通vqn下载入口-酷通npv官网地址-酷通加速器

Poxel completed a capital raise of EUR 17.7 million (USD 19.4 million) to accelerate development of PXL770 and PXL065 in NASH and to pursue early-stage opportunities for pipeline growth from its…

Read this Press Release: Poxel Provides Corporate Update and Reports Cash and Revenue for the Second Quarter and First Half 2025

酷通加速器-酷通vqn下载入口-酷通npv官网地址-酷通加速器

Shareholders approved all proposed resolutions   LYON, France--(BUSINESS WIRE)-- POXEL SA (Euronext: POXEL - FR0012432516), a biopharmaceutical company focused on the development of innovative treatments for…

Read this Press Release: Poxel Announces Results from June 24, 2025 Ordinary Annual and Extraordinary General Meeting
linux安装shadowsock Click here to show the next slide

酷通加速器-酷通vqn下载入口-酷通npv官网地址-酷通加速器

European Association for the Study of the Liver 2025 International Liver Congress

Click here to show the previous slide Click here to show the next slide
centos7搭建shadowsock
View Investor Relations
View Investor Presentation
极光加速器安全性如何  连接国外软件加速器  速帆加速器2.  黑洞vp加速器官网网址  黑豹加速connectionreset  电脑端使用的免费梯子  怎样可以上国外网站